# A Study in Healthy Volunteers and Patients With Chronic Hepatitis B

> **NCT02908191** · PHASE1 · COMPLETED · sponsor: **Assembly Biosciences** · enrollment: 86 (actual)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** ABI-H0731
- **DRUG:** Placebo for ABI-H0731
- **DRUG:** Entecavir
- **DRUG:** Tenofovir disoproxil fumarate
- **DRUG:** Pegasys
- **DRUG:** Nucleos(t)ide

## Key facts

- **NCT ID:** NCT02908191
- **Lead sponsor:** Assembly Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11
- **Primary completion:** 2018-03-31
- **Final completion:** 2018-06-12
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2019-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02908191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02908191, "A Study in Healthy Volunteers and Patients With Chronic Hepatitis B". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02908191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*